Evaluation of Renal Oxidative Stress in the Development of DOCA-Salt Induced Hypertension and Its Renal Damage

被引:37
作者
Seifi, Behjat [2 ]
Kadkhodaee, Mehri [1 ,2 ]
Karimian, Seyed M. [2 ]
Zahmatkesh, Maryam [2 ]
Xu, Jie [1 ]
Soleimani, Manoocher [1 ]
机构
[1] Univ Cincinnati, Dept Med, Cincinnati, OH 45221 USA
[2] Univ Tehran Med Sci, Sch Med, Dept Physiol, Tehran, Iran
关键词
renal; blood pressure; DOCA-salt; oxidative stress; antioxidants; HORMONE-INDUCED HYPERTENSION; ANTIOXIDANT STATUS; NADPH OXIDASE; VITAMIN-C; SUPEROXIDE-PRODUCTION; LIPID-PEROXIDATION; BLOOD-PRESSURE; GLUTATHIONE; PREVENTS; LIVER;
D O I
10.3109/10641960902993111
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
To ascertain the onset of renal oxidative stress and its interrelation with the increase in blood pressure (BP) and kidney injury in rats subjected to Deoxycorticosterone (DOCA)-salt treatment, BP, renal antioxidants, renal damage indices, and histological changes were studied weekly. In the two other groups, 200 mg/kg/day vitamin E or C were co-administered with DOCA-salt for 4 weeks. Blood Pressure was increased at week one. Urinary N-acetyl-B-diglucosaminidase (NAG) and proteinuria increased and renal catalase decreased at 2nd week. Histological changes and decreased glothatione (GSH) and Ferric reducing antioxidant power (FRAP) were demonstrated at three week. Vitamin therapy increased renal antioxidants and decreased BP, NAG, proteinuria, and histological damage. Thus, elevation in BP precedes the onset of renal oxidative stress in DOCA-salt treated rats. Enhanced renal oxidative stress contributes to kidney damage. In this study, treatment with vitamin C or vitamin E preserved renal antioxidant levels, prevented renal damage, and partially inhibited elevation of BP in the DOCA-salt treatment.</.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 35 条
[1]
AEBI H, 1984, METHOD ENZYMOL, V105, P121
[2]
The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': The FRAP assay [J].
Benzie, IFF ;
Strain, JJ .
ANALYTICAL BIOCHEMISTRY, 1996, 239 (01) :70-76
[3]
Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response [J].
Beswick, RA ;
Zhang, HF ;
Marable, D ;
Catravas, JD ;
Hill, WD ;
Webb, RC .
HYPERTENSION, 2001, 37 (02) :781-786
[4]
Antioxidant status in the liver of hypertensive and metallothionein-deficient mice [J].
Bobillier-Chaumont, S ;
Nicod, L ;
Richert, L ;
Berthelot, A .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (10) :929-936
[5]
Vitamin E:: function and metabolism [J].
Brigelius-Flohé, R ;
Traber, MG .
FASEB JOURNAL, 1999, 13 (10) :1145-1155
[6]
Callera GE, 2003, HYPERTENSION, V42, P811, DOI 10.1161/01.HYP.0000088363.65943.6C
[7]
Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney [J].
Chabrashvili, T ;
Tojo, A ;
Onozato, ML ;
Kitiyakara, C ;
Quinn, MT ;
Fujita, T ;
Welch, WJ ;
Wilcox, CS .
HYPERTENSION, 2002, 39 (02) :269-274
[8]
Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR [J].
Chen, X ;
Touyz, RM ;
Park, JB ;
Schiffrin, EL .
HYPERTENSION, 2001, 38 (03) :606-611
[9]
Courderot-Masuyer C, 2000, CELL MOL BIOL, V46, P1397
[10]
Protective effects of increasing vitamin E and A doses on cisplatin-induced oxidative damage to kidney tissue in rats [J].
Dillioglugil, MO ;
Kir, HM ;
Gulkac, MD ;
Kanli, AÖ ;
Ozdogan, HK ;
Acar, O ;
Dillioglugil, O .
UROLOGIA INTERNATIONALIS, 2005, 75 (04) :340-344